Showing results (81-90 of 96) with videos related to
Sort By:
Pageof 10
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 23, 2019
Cancer-related symptoms, mental well-being, and psychological distress in men diagnosed with prostate cancer treated with androgen deprivation therapySarah Wilding, Amy Downing, Penny Wright, et al.Cancer Epidemiology|October 1, 2020
Influence of deprivation and rurality on patient-reported outcomes of men living with and beyond prostate cancer diagnosis in the UK: A population-based studyLesley Smith, Amy Downing, Paul Norman, et al.Psycho-Oncology|February 18, 2020
Decision regret in men living with and beyond nonmetastatic prostate cancer in the United Kingdom: A population-based patient-reported outcome studySarah Wilding, Amy Downing, Peter Selby, et al.BMC Cancer|October 17, 2019
Quality of life among symptomatic compared to PSA-detected prostate cancer survivors - results from a UK wide patient-reported outcomes studyDavid W Donnelly, Linda C Vis, Therese Kearney, et al.European Urology|May 8, 2019
Regional Variations in Quality of Survival Among Men with Prostate Cancer Across the United KingdomDavid W Donnelly, Anna Gavin, Amy Downing, et al.The Lancet. Oncology|February 5, 2019
Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based studyAmy Downing, Penny Wright, Luke Hounsome, et al.BJU International|March 1, 2018
Urinary, bowel and sexual health in older men from Northern IrelandDavid W Donnelly, Conan Donnelly, Therese Kearney, et al.The Lancet. Oncology|February 29, 2024
Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based studySean McPhail, Matthew E Barclay, Shane A Johnson, et al.Cancer Epidemiology|September 12, 2025
Chemotherapy use in ovarian cancer patients diagnosed 2012-2017 in Australia, Canada, Norway and the UK: An International Cancer Benchmarking Partnership (ICBP) population-based studyMatthew E Barclay, Sean McPhail, Shane A Johnson, et al.The Lancet. Oncology|February 29, 2024
Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based studySean McPhail, Matthew E Barclay, Ruth Swann, et al.Pageof 10